Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


13.11.2017

1 Ann Surg Oncol
1 Biochem Biophys Res Commun
1 Br J Cancer
1 Bull Exp Biol Med
2 Cancer Med
1 Cancer Treat Rev
1 Cent European J Urol
1 Cureus
1 Diagn Cytopathol
1 Eur Urol
1 Fam Cancer
2 Int J Oncol
1 Int J Prev Med
2 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 J Cell Biochem
1 JMIR Res Protoc
3 Nature
1 Oncoimmunology
3 Oncol Lett
1 Oncotarget
1 Prostate
1 Sci Rep
1 Urol Oncol
1 Urologe A
1 Urologiia
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. ZHANG J, Zhu Y, Wang Y, Fu Q, et al
    Prognostic and Predictive Value of O6-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6145.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. ICHIKAWA H, Itsumi M, Kajioka S, Maki T, et al
    Overexpression of exchange protein directly activated by cAMP-1 (EPAC1) attenuates bladder cancer cell migration.
    Biochem Biophys Res Commun. 2017 Oct 27. pii: S0006-291X(17)32127.
    PubMed     Text format     Abstract available


    Br J Cancer

  3. KASHIWAGI E, Inoue S, Mizushima T, Chen J, et al
    Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Bull Exp Biol Med

  4. SHEGAY PV, Zhavoronkov AA, Gaifullin NM, Vorob'ev NV, et al
    Potentialities of MicroRNA Diagnosis in Patients with Bladder Cancer.
    Bull Exp Biol Med. 2017 Nov 9. doi: 10.1007/s10517-017-3935.
    PubMed     Text format     Abstract available


    Cancer Med

  5. RAMOS JD, Casey MF, Crabb SJ, Bamias A, et al
    Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
    Cancer Med. 2017;6:186-194.
    PubMed     Text format     Abstract available

  6. ROBSAHM TE, Falk RS, Heir T, Sandvik L, et al
    Cardiorespiratory fitness and risk of site-specific cancers: a long-term prospective cohort study.
    Cancer Med. 2017;6:865-873.
    PubMed     Text format     Abstract available


    Cancer Treat Rev

  7. CASADEVALL D, Kilian AY, Bellmunt J
    The prognostic role of epigenetic dysregulation in bladder cancer: A systematic review.
    Cancer Treat Rev. 2017;61:82-93.
    PubMed     Text format     Abstract available


    Cent European J Urol

  8. LEBENTRAU S, May M, Wick AK, Roiner M, et al
    Non-muscle invasive bladder cancer: Are epicrises the 'Bermuda Triangle' of information transfer?
    Cent European J Urol. 2017;70:245-251.
    PubMed     Text format     Abstract available


    Cureus

  9. KOCHAN A, Rivest R, Galloway K, Lambert P, et al
    Targeting the Tumor: Assessing the Impact of Bladder Volume and Position on Accuracy of Radiation Delivery for Patients with Bladder Cancer.
    Cureus. 2017;9:e1638.
    PubMed     Text format     Abstract available


    Diagn Cytopathol

  10. DEININGER S, Todenhofer T, Hennenlotter J, Gerber V, et al
    Impact of variant microscopic interpretation of the uCyt+ immunocytological urine test for the detection of bladder cancer.
    Diagn Cytopathol. 2017 Nov 8. doi: 10.1002/dc.23857.
    PubMed     Text format     Abstract available


    Eur Urol

  11. ABUFARAJ M, Dalbagni G, Daneshmand S, Horenblas S, et al
    The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review.
    Eur Urol. 2017 Nov 6. pii: S0302-2838(17)30840.
    PubMed     Text format     Abstract available


    Fam Cancer

  12. LI Q, Tang T, Zhang P, Liu C, et al
    Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.
    Fam Cancer. 2017 Nov 8. doi: 10.1007/s10689-017-0060.
    PubMed     Text format     Abstract available


    Int J Oncol

  13. LV XY, Ma L, Chen JF, Yu R, et al
    Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4195.
    PubMed     Text format     Abstract available

  14. KIM CJ, Terado T, Tambe Y, Mukaisho KI, et al
    Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4194.
    PubMed     Text format     Abstract available


    Int J Prev Med

  15. POUPEL F, Aghaei M, Movahedian A, Jafari SM, et al
    Dihydroartemisinin Induces Apoptosis in Human Bladder Cancer Cell Lines Through Reactive Oxygen Species, Mitochondrial Membrane Potential, and Cytochrome C Pathway.
    Int J Prev Med. 2017;8:78.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  16. KOK HP, Korshuize-van Straten L, Bakker A, de Kroon-Oldenhof R, et al
    Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.
    Int J Radiat Oncol Biol Phys. 2017;99:1039-1047.
    PubMed     Text format     Abstract available

  17. LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
    Online Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
    PubMed     Text format     Abstract available


    Int J Urol

  18. YANG X, Shi L, Yi C, Yang Y, et al
    Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
    Int J Urol. 2017 Nov 8. doi: 10.1111/iju.13486.
    PubMed     Text format     Abstract available


    J Cell Biochem

  19. XU ZQ, Yang MG, Liu HJ, Su CQ, et al
    Circular RNA hsa_circ_0003221 (circPTK2) promotes the proliferation and migration of bladder cancer cells.
    J Cell Biochem. 2017 Nov 10. doi: 10.1002/jcb.26492.
    PubMed     Text format     Abstract available


    JMIR Res Protoc

  20. RUTHERFORD C, King MT, Smith DP, Costa DS, et al
    Psychometric Evaluation of a Patient-Reported Symptom Index for Nonmuscle Invasive Bladder Cancer: Field Testing Protocol.
    JMIR Res Protoc. 2017;6:e216.
    PubMed     Text format     Abstract available


    Nature

  21. BERDIK C
    Unlocking bladder cancer.
    Nature. 2017;551:S34-S35.
    PubMed     Text format    

  22. BERDIK C
    Bladder cancer: 4 big questions.
    Nature. 2017;551:S51.
    PubMed     Text format    

  23. GRAYSON M
    Bladder cancer.
    Nature. 2017;551:S33.
    PubMed     Text format    


    Oncoimmunology

  24. PAQUETTE M, Vilera-Perez LG, Beaudoin S, Ekindi-Ndongo N, et al
    Targeting IL-5Ralpha with antibody-conjugates reveals a strategy for imaging and therapy for invasive bladder cancer.
    Oncoimmunology. 2017;6:e1331195.
    PubMed     Text format     Abstract available


    Oncol Lett

  25. CHEN Y, Wang H, Xiong T, Zou R, et al
    The role of LASS2 in regulating bladder cancer cell tumorigenicity in a nude mouse model.
    Oncol Lett. 2017;14:5149-5156.
    PubMed     Text format     Abstract available

  26. LUO J, Chen J, Li H, Yang Y, et al
    LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.
    Oncol Lett. 2017;14:5556-5562.
    PubMed     Text format     Abstract available

  27. ZHANG C, Wang YQ, Jin G, Wu S, et al
    Selection of reference genes for gene expression studies in human bladder cancer using SYBR-Green quantitative polymerase chain reaction.
    Oncol Lett. 2017;14:6001-6011.
    PubMed     Text format     Abstract available


    Oncotarget

  28. KIM HS, Jeong CW, Kwak C, Kim HH, et al
    Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials.
    Oncotarget. 2017;8:81204-81214.
    PubMed     Text format     Abstract available


    Prostate

  29. NEUZILLET Y, Raynaud JP, Radulescu C, Fiet J, et al
    Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).
    Prostate. 2017;77:1512-1519.
    PubMed     Text format     Abstract available


    Sci Rep

  30. SATO T, Katsuoka Y, Yoneda K, Nonomura M, et al
    Sniffer mice discriminate urine odours of patients with bladder cancer: A proof-of-principle study for non-invasive diagnosis of cancer-induced odours.
    Sci Rep. 2017;7:14628.
    PubMed     Text format     Abstract available


    Urol Oncol

  31. FAHMY O, Khairul-Asri MG, Schubert T, Renninger M, et al
    A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Urol Oncol. 2017 Oct 25. pii: S1078-1439(17)30529.
    PubMed     Text format     Abstract available


    Urologe A

  32. AEISHEN S, Dawood Y, Papadoukakis S, Horstmann M, et al
    [Supplementary optical techniques for the detection of nonmuscle invasive bladder cancer].
    Urologe A. 2017 Nov 6. doi: 10.1007/s00120-017-0539.
    PubMed     Text format     Abstract available


    Urologiia

  33. GLYBOCHKO PV, Alyaev YG, Shpot' EV, Pshi-Khachev AM, et al
    [Laparoscopic cystoprostatvesiculeectomy with orthotopic excentric ileal bladder substitution].
    Urologiia. 2017;:78-83.
    PubMed     Text format     Abstract available


    World J Urol

  34. FREES SK, Aning J, Black P, Struss W, et al
    A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer.
    World J Urol. 2017 Nov 7. doi: 10.1007/s00345-017-2109.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: